BlackRock Institutional Trust’s Veracyte VCYT Stock Holding History

BlackRock Institutional Trust’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.11M	Buy	142,872 +1,937	+1%	+$14.5K	﹤0.01%	3267
2016 Q3	$1.07M	Buy	140,935 +2,660	+2%	+$15K	﹤0.01%	3263
2016 Q2	$696K	Sell	138,275 -114	-0.1%	-$611	﹤0.01%	3423
2016 Q1	$747K	Sell	138,389 -2,996	-2%	-$17.7K	﹤0.01%	3364
2015 Q4	$1.02M	Buy	141,385 +12,811	+10%	+$86.3K	﹤0.01%	3319
2015 Q3	$603K	Buy	128,574 +21,403	+20%	+$204K	﹤0.01%	3458
2015 Q2	$1.07M	Buy	+107,171	New	+$1.06M	﹤0.01%	3339

Other funds holding VCYT

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

BlackRock Institutional Trust's VCYT Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Veracyte (VCYT) stake by 1.4% in Q4 2016, buying an estimated $14.5K and bringing the position to 142,872 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #3267.

BlackRock Institutional Trust first reported a position in VCYT in Q2 2015 and has held it in 7 quarters since. 74 funds tracked by Wall St. Rank hold VCYT as of Q4 2016.

BlackRock Institutional Trust held 142,872 shares of Veracyte worth $1.11M as of Q4 2016.
BlackRock Institutional Trust bought 1,937 Veracyte shares in Q4 2016, an estimated $14.5K.
Veracyte made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3267 holding.
BlackRock Institutional Trust first reported a position in Veracyte in Q2 2015 and has held it in 7 quarters since.
74 funds tracked by Wall St. Rank held Veracyte as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.